Thromboxane synthetase inhibition with CGS 13080 improves coronary blood flow after streptokinase-induced thrombolysis

This publication has 27 references indexed in Scilit:

• Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique
  Published by Elsevier ,2004
• IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• Augmentation of Streptokinase-Induced Thrombolysis by Heparin and Prostacyclin
  Journal of Cardiovascular Pharmacology, 1985
• The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction
  New England Journal of Medicine, 1985
• The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion.
  Circulation, 1984
• Selective and nonselective inhibition of thromboxane formation
  Clinical Pharmacology & Therapeutics, 1984
• The Effects of a New Thromboxane Synthetase Inhibitor, CGS‐13080, in Man
  The Journal of Clinical Pharmacology, 1984
• Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models
  Biochemical and Biophysical Research Communications, 1983
• Cardioprotective Effects of Ibuprofen in Experimental Regional and Global Myocardial Ischemia
  Journal of Cardiovascular Pharmacology, 1982
• Electrical induction of coronary artery thrombosis in the ambulatory canine: A model for evaluation of anti-thrombotic agents
  Thrombosis Research, 1980